Terms: = Ovarian cancer AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Treatment
27 results:
1. Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.
Bae SJ; Kim HJ; Kim HA; Ryu JM; Park S; Lee EG; Im SA; Jung Y; Park MH; Park KH; Kang SH; Park E; Kim SY; Lee MH; Kim LS; Lee A; Noh WC; Gwark S; Kim S; Jeong J
Int J Surg; 2024 Feb; 110(2):934-942. PubMed ID: 38000057
[TBL] [Abstract] [Full Text] [Related]
2. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract] [Full Text] [Related]
3. Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10.
Colomban O; Swisher EM; Kristeleit R; McNeish I; Shapira-Frommer R; Goble S; Lin KK; Maloney L; Freyer G; You B
EBioMedicine; 2023 Mar; 89():104477. PubMed ID: 36801617
[TBL] [Abstract] [Full Text] [Related]
4. Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study.
Liu X; Zhao Y; Jiao X; Yu Y; Li R; Zeng S; Chi J; Ma G; Huo Y; Li M; Peng Z; Liu J; Zhou Q; Zou D; Wang L; Li Q; Wang J; Yao S; Chen Y; Ma D; Hu T; Gao Q
BJOG; 2022 Nov; 129 Suppl 2():70-78. PubMed ID: 36485065
[TBL] [Abstract] [Full Text] [Related]
5. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
Yoshino K; Kurita T; Takahashi F; Nagase S;
J Obstet Gynaecol Res; 2022 Jul; 48(7):1570-1579. PubMed ID: 35633031
[TBL] [Abstract] [Full Text] [Related]
6. High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis.
Yan L; Huang H; Lin J; Yu R
Int J Hyperthermia; 2022; 39(1):230-238. PubMed ID: 35094613
[TBL] [Abstract] [Full Text] [Related]
7. Perioperative outcomes in a nationwide sample of patients undergoing surgical treatment of ovarian endometriomas.
Orlando MS; Yao M; Chang OH; Shippey E; Bosko T; Cadish L; Falcone T; Kho RM
Fertil Steril; 2022 Feb; 117(2):444-453. PubMed ID: 34802687
[TBL] [Abstract] [Full Text] [Related]
8. Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries.
Oskay-Özcelik G; Alavi S; Richter R; Keller M; Chekerov R; Cecere SC; Cormio G; Joly F; Kurtz JE; du Bois A; Maciejewski M; Jedryka M; Vergote I; Van Nieuwenhuysen E; Casado A; Mendiola C; Achimas-Cadariu P; Vlad C; Reimer D; Zeimet AG; Friedlander M; Sehouli J
Ann Oncol; 2018 Apr; 29(4):910-916. PubMed ID: 29415128
[TBL] [Abstract] [Full Text] [Related]
9. Pelvic floor disorders in women with gynecologic malignancies: a systematic review.
Ramaseshan AS; Felton J; Roque D; Rao G; Shipper AG; Sanses TVD
Int Urogynecol J; 2018 Apr; 29(4):459-476. PubMed ID: 28929201
[TBL] [Abstract] [Full Text] [Related]
10. A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.
Eoh KJ; Yoon JW; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
BMC Cancer; 2017 Jul; 17(1):481. PubMed ID: 28701190
[TBL] [Abstract] [Full Text] [Related]
11. Trends and Patterns of Disparities in cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
12. Effect of first line cancer treatment on the ovarian reserve and follicular density in girls under the age of 18 years.
El Issaoui M; Giorgione V; Mamsen LS; Rechnitzer C; Birkebæk N; Clausen N; Kelsey TW; Andersen CY
Fertil Steril; 2016 Dec; 106(7):1757-1762.e1. PubMed ID: 27717554
[TBL] [Abstract] [Full Text] [Related]
13. The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.
Huzarski T; Byrski T; Gronwald J; Cybulski C; Oszurek O; Szwiec M; Gugała K; Stawicka M; Morawiec Z; Mierzwa T; Falco M; Janiszewska H; Kilar E; Marczyk E; Kozak-Klonowska B; Siołek M; Surdyka D; Wiśniowski R; Posmyk M; Domagała P; Sun P; Lubiński J; Narod SA;
Breast Cancer Res Treat; 2016 Apr; 156(2):371-8. PubMed ID: 26983446
[TBL] [Abstract] [Full Text] [Related]
14. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract] [Full Text] [Related]
15. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer.
Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D
Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000
[TBL] [Abstract] [Full Text] [Related]
16. Cost-effectiveness of trabectedin plus pegylated liposomal doxorubicin for the treatment of women with relapsed platinum-sensitive ovarian cancer in the UK: analysis based on the final survival data of the OVA-301 trial.
Fisher M; Gore M
Value Health; 2013 Jun; 16(4):507-16. PubMed ID: 23796284
[TBL] [Abstract] [Full Text] [Related]
17. A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice.
Van Belle S; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Aerts JG
Curr Med Res Opin; 2012 Jul; 28(7):1079-87. PubMed ID: 22642867
[TBL] [Abstract] [Full Text] [Related]
18. Clinical research in epithelial ovarian cancer and patients' outcome.
Rochon J; du Bois A
Ann Oncol; 2011 Nov; 22 Suppl 7():vii16-vii19. PubMed ID: 22039139
[TBL] [Abstract] [Full Text] [Related]
19. [Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer].
Zhao D; Wu LY; Li XG; Wang XB; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Zhang W
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):855-8. PubMed ID: 21223693
[TBL] [Abstract] [Full Text] [Related]
20. Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications.
Dovern E; de Hingh IH; Verwaal VJ; van Driel WJ; Nienhuijs SW
Eur J Gynaecol Oncol; 2010; 31(3):256-61. PubMed ID: 21077465
[TBL] [Abstract] [Full Text] [Related]
[Next]
